Search Results 81-90 of 15967 for GLP-1 agonist
acarbose). Furthermore, by confining the recommendations to oral medications, another class of injectable medication – glucagon-like peptide-1 receptor agonists ...
Contraindications to GLP-1 receptor agonist therapy as per Tirzepatide (Zepbound ®) label. Currently enrolled in another clinical study involving an ...
Treatment with GLP-1 agonists and amlyin which cause vagal blockade and may affect central processing of pain; Use of tobacco products within the past six ...
... GLP-1 agonists used for diabetes and tricyclic antidepressants at high doses), neurological disorders, and autoimmune disorders. Published in 2021, the ...
Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia. Anesth Analg. 2026 Apr 1; 142 ...
Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor Agonist Use in Routine Clinical Practice: Comparative Effectiveness of ...
The purpose of this study is to evaluate the effectiveness and safety of vibegron, a beta-3 adrenergic receptor (β3-AR) agonist, in the treatment of pain ...
Management of obesity within hepatology clinics. Researchers discuss the role of dietary supplements, glucagon-like peptide 1 receptor agonists, sodium-glucose ...
Mishra S, Persons PA, Bersoux S. Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period? Cleve Clin J Med. 2025 Apr 1; 92 ( ...
Early glucagon-like peptide-1 receptor agonist use after myocardial infarction in patients with type 2 diabetes. ... GLP-1 Receptor Agonists and Clinical Outcomes ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.